SecBot SecBot
6-K ·Filed Oct 29, 2026

ACB

AURORA CANNABIS INC
NEUTRAL
Impact 2/10
Horizondays Processed6d 13h ago SEC0001104659-26-119872
Notable filing: 6-K
Actionable Insight • Neutral

Monitor the November 12 earnings release for Q2 2027 revenue, margins, and any update on the Curaleaf hostile bid. The stock's reaction will depend on the financial results, not this scheduling notice.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$4.08
T+0 close · Oct 29, 2026 · via day close
Latest settled
−0.49%
T+1 · $4.06 · next T+5 in 11h
vs SPY
+1.28%
α at T+1
Latest observation
+5.12%
T+2 · FF3 residual α
  1. T+0 · Oct 29 $4.08entry
  2. T+1 · 6d ago −0.49%α +1.28% · $4.06
  3. T+4 · todayOpen
  4. T+5 · in 11h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Aurora Cannabis filed a 6-K announcing the date of its fiscal Q2 2027 earnings release and investor conference call on November 12, 2026. The filing also reiterates the board's recommendation to reject Curaleaf's hostile bid. No financial results are disclosed.

Key Facts

  • Aurora will report Q2 2027 financial results and host a conference call on November 12, 2026 at 8:00 a.m. ET.
  • The filing reminds shareholders to reject Curaleaf's hostile bid and not tender shares.
  • No financial data, guidance, or material operational updates are provided in this filing.

Financial Impact

No financial figures disclosed; routine earnings date announcement.

Risk Factors

  • The hostile bid from Curaleaf creates ongoing uncertainty; shareholder response and regulatory developments could affect the stock.
  • No financial data in this filing leaves the near-term outlook unaddressed until the earnings call.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-119872
Document: tm2628516d1_6k.htm0001104659-26-119872
Document: 0001104659-26-119872-index-headers.html0001104659-26-119872
Document: 0001104659-26-119872-index.html0001104659-26-119872
Document: 0001104659-26-119872.txt0001104659-26-119872
32 reports for ACB
Performance horizon
50% Hit rate @ T+5 4 of 8 bullish or bearish reports Went positive at some point 6 of 9 best @ T+5▲ +3.26%Apr 15, 2026
Filters
Rows
Reports for ACB, sortable and filterable
TypeNow
Nov 4, 2026
today
6-K
BULLISH ★ 7/10
$5.15awaiting T+5awaiting T+5$5.24 (+1.75%)
Nov 3, 2026
1d ago
6-K
BULLISH ★ 7/10
$5.16awaiting T+5awaiting T+5$5.24 (+1.55%)
Oct 29, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$4.08awaiting T+5awaiting T+5$5.24 (+28.43%)
Oct 26, 2026
9d ago
6-K
NEUTRAL ★ 4/10
$3.90 $4.06▲ +4.10%▲ +5.36%$5.24 (+34.36%)
Oct 14, 2026
21d ago
6-K
NEUTRAL ★ 6/10
$4.10 $3.97▼ −3.17%▼ −2.16%$5.24 (+27.80%)
Oct 8, 2026
27d ago
6-K
NEUTRAL ★ 4/10
$4.43 $4.10▼ −7.45%▼ −7.17%$5.24 (+18.28%)
Oct 6, 2026
29d ago
6-K
NEUTRAL ★ 6/10
$4.46 $4.17▼ −6.50%▼ −5.52%$5.24 (+17.49%)
Oct 5, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$4.59 $4.29▼ −6.54%▼ −6.40%$5.24 (+14.16%)
Sep 16, 2026
7w ago
6-K
NEUTRAL ★ 4/10
$3.83 $4.22▲ +10.18%▲ +7.62%$5.24 (+36.81%)
Sep 14, 2026
7w ago
6-K
NEUTRAL ★ 5/10
$3.81 $4.03▲ +5.77%▲ +5.67%$5.24 (+37.53%)
Showing 10 of 32

US Market Status

Market Closed · Opens Fri (13h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026